KLRK1 and cancer: A recent study showed that desialylation of cancer cells reduced natural killer cell inhibitory sialic acid-binding Ig-like lectin (Siglec) receptors, and increased natural killer cell activating receptor natural killer group 2D (NKG2D), suggesting a precise sialylation editing method for cancer targeting immune therapy [26].